Systematic review: Role of acid, weakly acidic and weakly alkaline reflux in gastro-oesophageal reflux disease

Alimentary Pharmacology and Therapeutics

Volumn 32, Issue 3, 2010, Pages 334-343

  Boeckxstaens, G E ^a,b   Smout, A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

ACIDITY; ALKALINITY; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; DISEASE ASSOCIATION; EMBASE; GASTRIC PH MONITORING; GASTROESOPHAGEAL REFLUX; HUMAN; MEDLINE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT INDICATION;

ADULT; FEMALE; GASTRIC ACIDITY DETERMINATION; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; PROTON PUMP INHIBITORS;

EID: 77954325945     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04358.x     Document Type: Review

References (44)

1. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005 54:710 717.
2. Vakil N, Veldhuyzen van Zanten S, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastro-esophageal reflux disease (GERD) - a global evidence-based consensus. Am J Gastroenterol 2006 101:1900 1920.
3. Bredenoord AJ, Weusten BL, Curvers WL, Timmer R, Smout AJ. Determinants of perception of heartburn and regurgitation. Gut 2006 55:313 318.
4. Boeckxstaens GE. The lower oesophageal sphincter. Neurogastroenterol Motil 2005 17 (Suppl 1 13 21.
5. Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 2004 53:1024 1031.
6. Hirano I, Richter JE. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol 2007 102:668 685.
7. Sifrim D, Silny J, Holloway RH, Janssens JJ. Patterns of gas and liquid reflux during transient lower oesophageal sphincter relaxation: a study using intraluminal electrical impedance. Gut 1999 44:47 54.
8. Sifrim D, Mittal R, Fass R, et al. Review article: Acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms. Aliment Pharmacol Ther 2007 25:1003 1015.
9. Bland JM, Kerry SM. Statistics notes. Weighted comparison of means. BMJ 1998 316:129.
10. Orr WC, Craddock A, Goodrich S. Acidic and non-acidic reflux during sleep under conditions of powerful acid suppression. Chest 2007 131:460 465.
11. Emerenziani S, Sifrim D, Habib FI, et al. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus. Gut 2008 57:443 447.
12. Blonski W, Vela MF, Castell DO. Comparison of reflux frequency during prolonged multichannel intraluminal impedance and pH monitoring on and off acid suppression therapy. J Clin Gastroenterol 2009 43:816 820.
13. Vela MF, Camacho-Lobato L, Srinivasan R, Tutuian R, Katz PO, Castell DO. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology 2001 120:1599 1606.
14. Weigt J, Monkemuller K, Peitz U, Malfertheiner P. Multichannel intraluminal impedance and pH-metry for investigation of symptomatic gastroesophageal reflux disease. Dig Dis 2007 25:179 182.
15. Zerbib F, Duriez A, Roman S, Capdepont M, Mion F. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors. Gut 2008 57:156 160.
16. Iwakiri K, Kawami N, Sano H, et al. Acid and non-acid reflux in Japanese patients with non-erosive reflux disease with persistent reflux symptoms, despite taking a double-dose of proton pump inhibitor: a study using combined pH-impedance monitoring. J Gastroenterol 2009 44:708 712.
17. Tutuian R, Vela MF, Hill EG, Mainie I, Agrawal A, Castell DO. Characteristics of symptomatic reflux episodes on acid suppressive therapy. Am J Gastroenterol 2008 103:1090 1096.
18. Vela MF, Tutuian R, Katz PO, Castell DO. Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment Pharmacol Ther 2003 17:243 251.
19. Bredenoord AJ, Hemmink GJ, Smout AJ. Relationship between gastro-oesophageal reflux pattern and severity of mucosal damage. Neurogastroenterol Motil 2009 21:807 812.
20. Conchillo JM, Schwartz MP, Selimah M, Samsom M, Sifrim D, Smout AJ. Acid and non-acid reflux patterns in patients with erosive esophagitis and non-erosive reflux disease (NERD): A study using intraluminal impedance monitoring. Dig Dis Sci 2008 53:1506 1512.
21. Pace F, Sangaletti O, Pallotta S, Molteni P, Porro GB. Biliary reflux and non-acid reflux are two distinct phenomena: A comparison between 24-hour multichannel intraesophageal impedance and bilirubin monitoring. Scand J Gastroenterol 2007 42:1031 1039.
22. Xiao YL, Lin JK, Cheung TK, et al. Reflux profile of Chinese gastroesophageal reflux disease patients with combined multichannel intraluminal impedance-pH monitoring. J Gastroenterol Hepatol 2009 24:1113 1118.
23. Emerenziani S, Ribolsi M, Sifrim D, Blondeau K, Cicala M. Regional oesophageal sensitivity to acid and weakly acidic reflux in patients with non-erosive reflux disease. Neurogastroenterol Motil 2009 21:235 238.
24. Dent J. Review article: from 1906 to 2006 - a century of major evolution of understanding of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2006 24:1269 1281.
25. 2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev 2004 4:CD002095.
26. Donnellan C, Sharma N, Preston C, Moayyedi P. Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease. Cochrane Database Syst Rev 2005 4:CD003245.
27. Sharma P, Shaheen NJ, Perez MC, et al. Clinical trials: healing of erosive oesophagitis with dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed-release formulation - results from two randomized controlled studies. Aliment Pharmacol Ther 2009 29:731 741.
28. Dent J, Kahrilas PJ, Hatlebakk J, et al. A randomized, comparative trial of a potassium-competitive acid blocker (AZD0865) and esomeprazole for the treatment of patients with nonerosive reflux disease. Am J Gastroenterol 2008 103:20 6.
29. Boeckxstaens GE. Reflux inhibitors: a new approach for GERD? Curr Opin Pharmacol 2008 8:685 689.
30. Boeckxstaens GE, Rydholm H, Adler J, Ruth M. Effect of AZD3355, a novel GABA(B) receptor agonist, on transient lower esophageal sphincter relaxations in healthy subjects. Gastroenterol 2009 136 (Suppl 1 772.
31. Keywood C, Wakefield M, Tack J. A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease. Gut 2009 58:1192 1199.
32. del Genio G, Tolone S, del Genio F, et al. Total fundoplication controls acid and nonacid reflux: evaluation by pre- and postoperative 24-h pH-multichannel intraluminal impedance. Surg Endosc 2008 22:2518 2523.
33. Conchillo JM, Schwartz MP, Selimah M, et al. Role of intra-oesophageal impedance monitoring in the evaluation of endoscopic gastroplication for gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2007 26:61 8.
34. Fass R, Naliboff B, Higa L, et al. Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology 1998 115:1363 1373.
35. Takeda T, Nabae T, Kassab G, Liu J, Mittal RK. Oesophageal wall stretch: the stimulus for distension induced oesophageal sensation. Neurogastroenterol Motil 2004 16:721 728.
36. Bredenoord AJ, Weusten BL, Timmer R, Smout AJ. Characteristics of gastroesophageal reflux in symptomatic patients with and without excessive esophageal acid exposure. Am J Gastroenterol 2006 101:2470 2475.
37. Beaumont H, Bennink R, de Jong J, Boeckxstaens G. The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and GERD patients. Gut 2010 59:441 451.
38. Aanen MC, Bredenoord AJ, Samsom M, Smout AJ. Reliability of oesophageal pH recording for the detection of gastro-oesophageal reflux. Scand J Gastroenterol 2008 43:1442 1447.
39. Beaumont H, Boeckxstaens GE. Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy? Am J Gastroenterol 2009 104:1764 1771.
40. Bredenoord AJ, Weusten BL, Timmer R, Smout AJ. Air swallowing, belching, and reflux in patients with gastroesophageal reflux disease. Am J Gastroenterol 2006 101:1721 1726.
41. Bredenoord AJ, Draaisma WA, Weusten BL, Gooszen HG, Smout AJ. Mechanisms of acid, weakly acidic and gas reflux after anti-reflux surgery. Gut 2008 57:161 166.
42. Hemmink GJM, Bredenoord AJ, Weusten BLAM, Monkelbaan JF, Timmer R, Smout AJPM. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'On' or 'off' proton pump inhibitor? Am J Gastroenterol 2008 103:2446 2453.
43. Khan A, Cho I, Traube M. Patients with throat symptoms on acid suppressive therapy: do they have reflux? Dig Dis Sci 2010 55:346 350.
44. Zentilin P, Dulbecco P, Savarino E, et al. An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry. Aliment Pharmacol Ther 2005 21:29 34.